市场调查报告书
商品编码
1410844
心臟瓣膜修復设备市场:市场规模(按细分市场)、份额、监管、报销、程序、预测(~2033)Cardiac Valve Repair Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
由于退化性病因的增加,瓣膜性心臟病的盛行率随着年龄的增长而增加。葡萄球菌性心内膜炎是瓣膜性心臟病的重要病因。主动脉瓣和二尖瓣最常受到瓣膜性心臟病的影响。二尖瓣关闭不全会导致左心房扩张、心房颤动、肺动脉压力升高、劳力性呼吸困难。退化性二尖瓣逆流导致索状瓣膜伸长和破裂以及瓣叶脱垂。
该报告深入探讨了全球心臟瓣膜修復设备市场,包括竞争格局、SWOT 分析、到 2033 年的市场预测、COVID-19 的影响以及区域和国家趋势。
Cardiac Valve Repair Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.
The model discusses in detail the impact of COVID-19 on Cardiac Valve Repair Devices market for the year 2020 and beyond. The prevalence of valvular heart disease increases with age because of the increase in degenerative etiologies. Endocarditis which is caused by Staphylococci is an important etiology of valvular heart disease. The aortic valve and mitral valve are most commonly affected by valvular heart disease. Mitral valve regurgitation can further lead to exertional dyspnea along with left atrial dilation, atrial fibrillation, and elevated pulmonary atrial pressure. Degenerative mitral regurgitation also leads to chordal elongation or rupture and causes leaflet prolapse.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Cardiac Valve Repair Devices market and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Edwards Lifesciences Corp, Medtronic Plc, Abbott Laboratories, Corcym Srl, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable